Courtesy of Belift Lab
 |
| ▲ Courtesy of Belift Lab |
K-pop group Enhypen, through agency Belift Lab, disclosed details for the Japanese leg of their encore tour, Fate Plus, on Monday. The tour will span from June to September, with the band performing in five cities across the country: Saitama, Fukuoka, Hiroshima, Aichi, and Miyagi. This tour marks Enhypen's largest series of concerts in Japan to date, totaling 11 shows.
Prior to their Japanese tour, Enhypen will embark on a tour in the United States, visiting five cities from April to May. The tour will include performances in two cities in California, as well as one each in Washington, Illinois, and New York.
Recently, the band members returned from Shanghai following an autograph session to promote their fifth EP, "Orange Blood." Released in November of the previous year, the EP has achieved significant success, selling over 2 million copies as of last week. Notably, "Orange Blood" debuted at No. 4 on the Billboard 200 chart and maintained its position for seven consecutive weeks. Additionally, it topped both Oricon's weekly and weekly combined album rankings.
Sayart
Sayart, sayart2022@gmail.com
Belift Lab Reveals Extensive Concert Plans and Recent Achievements for K-pop Sensation
Courtesy of Belift Lab
|
| ▲ Courtesy of Belift Lab |
K-pop group Enhypen, through agency Belift Lab, disclosed details for the Japanese leg of their encore tour, Fate Plus, on Monday. The tour will span from June to September, with the band performing in five cities across the country: Saitama, Fukuoka, Hiroshima, Aichi, and Miyagi. This tour marks Enhypen's largest series of concerts in Japan to date, totaling 11 shows.
Prior to their Japanese tour, Enhypen will embark on a tour in the United States, visiting five cities from April to May. The tour will include performances in two cities in California, as well as one each in Washington, Illinois, and New York.
Recently, the band members returned from Shanghai following an autograph session to promote their fifth EP, "Orange Blood." Released in November of the previous year, the EP has achieved significant success, selling over 2 million copies as of last week. Notably, "Orange Blood" debuted at No. 4 on the Billboard 200 chart and maintained its position for seven consecutive weeks. Additionally, it topped both Oricon's weekly and weekly combined album rankings.
Sayart
Sayart, sayart2022@gmail.com
Related articles
- Babymonster Announces "See You There" Tour Across Asia
- NewJeans' "Hype Boy" Surpasses 500 Million Spotify Plays
- NCT's Taeyong to Commence Mandatory Military Service on April 15
- YG Entertainment's Babymonster Prepares for Debut EP Release with Dark Hip-Hop Track
